Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
SAM Clinical Research Center
mi
from
San Antonio, TX
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
SAM Clinical Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Sugarland Cardiology Associates
mi
from
Sugarland, TX
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Sugarland Cardiology Associates
mi
from
Sugarland, TX
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Scott & White Memorial Hospital
mi
from
Temple, TX
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Northwest Heart Center
mi
from
Tomball, TX
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Northwest Heart Center
mi
from
Tomball, TX
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Tyler Cardiovascular Consultants
mi
from
Tyler, TX
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Tyler Cardiovascular Consultants
mi
from
Tyler, TX
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Utah Cardiology PC
mi
from
Layton, UT
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Utah Cardiology PC
mi
from
Layton, UT
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Bermisa Family Practice & Research Center
mi
from
Chesapeake, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Bermisa Family Practice & Research Center
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Zakhary, Bosh
mi
from
Danville, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Zakhary, Bosh
mi
from
Danville, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Heart Care Associates PC
mi
from
Hopewell, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Heart Care Associates PC
mi
from
Hopewell, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
The Cardiology Group Centra.
mi
from
Lynchburg, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
The Cardiology Group Centra.
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Virginia Cardiolovascular Associates
mi
from
Manassas, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Virginia Cardiolovascular Associates
mi
from
Manassas, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Midlothian, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Midlothian, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Sendara Cardiovasular Research Institute
mi
from
Norfolk, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Sendara Cardiovasular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Virgina Commonwealth Universitymedical Center
mi
from
Richmond, VA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Virgina Commonwealth Universitymedical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Inland Cardiology Associates
mi
from
Spokane, WA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Inland Cardiology Associates
mi
from
Spokane, WA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Franciscan Research Center
mi
from
Tacoma, WA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Franciscan Research Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Dean And St. Mary'S Outpatient Center
mi
from
Madison, WI
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Dean And St. Mary'S Outpatient Center
mi
from
Madison, WI
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Wheaton Franciscan Healthcare-St. Joseph
mi
from
Milwaukee, WI
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Wheaton Franciscan Healthcare-St. Joseph
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Berazategui,
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Berazategui,
Click here to add this to my saved trials
Education and Counseling for Abstinence From Tobacco After Pregnancy
Postpartum Maintenance of Abstinence From Tobacco
Status: Enrolling
Updated:  12/21/2015
Brown University
mi
from
Providence, RI
Education and Counseling for Abstinence From Tobacco After Pregnancy
Postpartum Maintenance of Abstinence From Tobacco
Status: Enrolling
Updated: 12/21/2015
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Status: Enrolling
Updated:  12/21/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Status: Enrolling
Updated: 12/21/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Arkansas Heart Hospital
mi
from
Little Rock, AR
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Glendale Adventist Medical Center
mi
from
Glendale, CA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Glendale Adventist Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
The Hartford Hospital
mi
from
Hartford, CT
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
MedStar Washington Hospital
mi
from
Washington,
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
MedStar Washington Hospital
mi
from
Washington,
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Clearwater Cardiovascular & Interventional Consultants, MD, PA
mi
from
Clearwater, FL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Clearwater Cardiovascular & Interventional Consultants, MD, PA
mi
from
Clearwater, FL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Mount Sinai Medical Center Heart Institute
mi
from
Miami Beach, FL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Mount Sinai Medical Center Heart Institute
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Cardiovascular Institute of NW Florida
mi
from
Panama City, FL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Cardiovascular Institute of NW Florida
mi
from
Panama City, FL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Georgia Regents Research Institute
mi
from
Augusta, GA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Georgia Regents Research Institute
mi
from
Augusta, GA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Indiana University
mi
from
Indianapolis, IN
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
John Hopkins
mi
from
Baltimore, MD
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
John Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Tufts Medical Center
mi
from
Boston, MA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Baystate Medical Center
mi
from
Springfield, MA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
McLaren Bay Regional
mi
from
Bay City, MI
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
McLaren Bay Regional
mi
from
Bay City, MI
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Beaumont Hospital
mi
from
Royal Oak, MI
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Boone Hospital
mi
from
Columbia, MO
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Boone Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Saint Luke's
mi
from
Kansas City, MO
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Saint Luke's
mi
from
Kansas City, MO
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Hackensack University Medical Center
mi
from
Hackensack, NJ
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Jersey Shore Medical Center
mi
from
Neptune, NJ
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Jersey Shore Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Mount Sinai New York
mi
from
New York City, NY
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Mount Sinai New York
mi
from
New York City, NY
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
East Carolina University
mi
from
Greenville, NC
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
North Carolina Heart & Vascular Specialists
mi
from
Raleigh, NC
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
North Carolina Heart & Vascular Specialists
mi
from
Raleigh, NC
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
OhioHealth Research Institute
mi
from
Columbus, OH
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
OhioHealth Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
St. John Health System
mi
from
Tulsa, OK
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
St. John Health System
mi
from
Tulsa, OK
Click here to add this to my saved trials
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated:  12/21/2015
University Pittsburg MC - Hamot
mi
from
Erie, PA
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Status: Enrolling
Updated: 12/21/2015
University Pittsburg MC - Hamot
mi
from
Erie, PA
Click here to add this to my saved trials